The store will not work correctly when cookies are disabled.
3-Phenyl-5-(2-hydroxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102939
PubChem CID: 72792827
Max Phase: Preclinical
Molecular Formula: C19H14N2O
Molecular Weight: 286.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1ccccc1-c1cnc2[nH]cc(-c3ccccc3)c2c1
Standard InChI: InChI=1S/C19H14N2O/c22-18-9-5-4-8-15(18)14-10-16-17(12-21-19(16)20-11-14)13-6-2-1-3-7-13/h1-12,22H,(H,20,21)
Standard InChI Key: CDOBVHIGUHJGGX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
2.4140 -13.3179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4128 -14.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1272 -14.5575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1254 -12.9055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6998 -12.9059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8405 -13.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8408 -14.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6307 -14.4014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1188 -13.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6303 -13.0575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0181 -12.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8428 -12.3056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2310 -11.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7949 -10.8781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9666 -10.9085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5822 -11.6357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7030 -12.0803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9897 -11.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2746 -12.0808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2775 -12.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9915 -13.3179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9945 -14.1425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
21 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.33 | Molecular Weight (Monoisotopic): 286.1106 | AlogP: 4.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.91 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.64 | CX Basic pKa: 2.84 | CX LogP: 4.21 | CX LogD: 4.21 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.57 | Np Likeness Score: -0.08 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |